Longenesis, a medical technology startup company, has joined the Chamber as a Corporate member. The startup is working towards providing a technological bridge between Healthcare institutions and the BioTech industry with an aim to help identify and unlock the hidden value of biomedical data to accelerate the novel drug and treatment discovery and provide better help to those in need.

Their team has experience working with the clinical organizations and unlocking the potential for accelerating the R&D process around the globe, including National level projects in the Middle East, U.S., Baltic and APAC regions.

In the Chamber it will be represented by Emil Syundyukov, Chief Technology Officer.

A warm welcome to AmCham community!